Recombinant Human IGFBP-4 protein (His Tag)

种属

Human

纯度

>95 %, SDS-PAGE

标签

His Tag

生物活性

EC50: 0.025-0.1µg/mL

Cat no : Eg0825

Print datasheet

Synonyms

IGFBP4, BP 4, BP4, Deb2, HT29 IGFBP



产品信息

纯度 >95 %, SDS-PAGE
内毒素 <0.1 EU/μg protein, LAL method
生物活性 Measured by its ability to inhibit the biological activity of IGF-I or IGF-II on MCF-7 human breast cancer cells. The EC50 for this effect is 0.025-0.1µg/mL in the presence of 30 ng/mL Recombinant Human IGF-I.
来源 HEK293-derived Human IGFBP-4 protein Asp22-Glu258 (Accession# P22692-1) with a His tag at the C-terminus.
基因ID 3487
蛋白编号 P22692-1
预测分子量 26.8 kDa
SDS-PAGE 27-32 kDa, reducing (R) conditions
组分 Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization.
复溶 Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water.
储存条件
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
  • Until expiry date, -20℃ to -80℃ as lyophilized proteins.
  • 3 months, -20℃ to -80℃ under sterile conditions after reconstitution.
运输条件 The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature.

背景信息

IGFBP4, also named as IBP4, is a 258 amino acid protein, which contains one IGFBP N-terminal domain and one thyroglobulin type-1 domain. IGFBP4 is the smallest member of the insulin-like growth factor binding protein family (IGFBP). It is a hepatic protein that plays a role in modulating the activity and bioavailability of IGF-I. The expression of IGFBP4 was found to increase under conditions of hypoxia. IGFBP4 is highly expressed in adipocytes and osteoblasts and is inhibitory of IGFs in vitro.

参考文献:

1.Maridas, David E et al. (2017). Endocrinology. 158(10):3488-3500. 2.Alterki, Abdulmohsen et al. (2021). Disease markers.1219593. 3.Ruan, Peng et al. (2023). Cell Biol Toxicol. 39(4):1611-1626.